MG
MHUA

Marex Group’s Meihua International Medical Technologies MHUA Stock Holding History

Marex Group’s Portfolio MHUA Stock Details MHUA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-252
Closed -$9.46K – 1077
2025
Q3 		$9.46K Buy
252
+90
+56% +$3.68K ﹤0.01% 829
2025
Q2 		$6.49K Buy
162
+42
+35% +$1.55K ﹤0.01% 634
2025
Q1 		$4.03K Buy
+120
New +$3.96K ﹤0.01% 679
2024
Q4 		– Sell
-250
Closed -$25.5K – 772
2024
Q3 		$25.5K Buy
250
+50
+25% +$4.58K ﹤0.01% 576
2024
Q2 		$17.1K Buy
200
+83
+71% +$5.95K ﹤0.01% 617
2024
Q1 		$8.94K Buy
+117
New +$10.3K ﹤0.01% 464

Marex Group's MHUA Position: Q4 2025 in Review

Marex Group sold out of Meihua International Medical Technologies (MHUA) in Q4 2025, closing a stake of 252 shares — an estimated $9.46K sold.

Marex Group first reported a position in MHUA in Q1 2024 and held it in 6 quarters. The position peaked at $25.5K in Q3 2024. 0 funds tracked by Wall St. Rank hold MHUA as of Q4 2025.

  • Marex Group reported no remaining Meihua International Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Marex Group sold 252 Meihua International Medical Technologies shares in Q4 2025, an estimated $9.46K.
  • Marex Group first reported a position in Meihua International Medical Technologies in Q1 2024 and held it in 6 quarters.
  • Marex Group's Meihua International Medical Technologies position peaked at $25.5K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.